Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Johane P. Allard's publication output changed over time?
ScholarIQpublication output · 1998–2023
Output grew0% over the shown period — from 1 works in 1998 to 1 in 2023.
1
1
1
1
3
2
1
1
1
199820072011201320152016201820212023
What are the most-cited papers on Johane P. Allard?
ScholarIQmost cited works
Intestinal microbiota in patients with nonalcoholic fatty liver disease
Marialena Mouzaki, Elena M. Comelli, Bianca M. Arendt, Julia Bonengel, Scott Fung, Sandra E. Fischer, Ian D. McGilvray, Johane P. Allard
S156174673. 2013742 CitationsOPEN ACCESS
Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome
Palle Bekker Jeppesen, Richard Gilroy, M. Pertkiewicz, Johane P. Allard, Bernard Messing, Stephen J. O’Keefe
Gut. 2011452 CitationsOPEN ACCESS
Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease
Marialena Mouzaki, Alice Y. Wang, Robert Bandsma, Elena M. Comelli, Bianca M. Arendt, Ling Zhang, Scott Fung, Sandra E. Fischer, Ian G. McGilvray, Johane P. Allard
PLoS ONE. 2016389 CitationsOPEN ACCESS
Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n‐3 and n‐6 polyunsaturated fatty acids
Bianca M. Arendt, Elena M. Comelli, David W.L., Wendy Lou, Anastasia Teterina, Tae‐Hyung Kim, Scott Fung, David Wong, Ian D. McGilvray, Sandra E. Fischer, Johane P. Allard
S156174673. 2015346 CitationsOPEN ACCESS
Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance
Hannah E. Da Silva, Anastasia Teterina, Elena M. Comelli, Amel Taïbi, Bianca M. Arendt, Sandra E. Fischer, Wendy Lou, Johane P. Allard
Scientific Reports. 2018281 CitationsOPEN ACCESS
Related on ScholarIQ
University Health Network
Institution
Intestinal microbiota in patients with nonalcoholic fatty liver disease
Paper
Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome
Paper
Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease
Paper
Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n‐3 and n‐6 polyunsaturated fatty acids
Paper
Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance
Paper